Valuation: Abbott India Limited

Market Cap 566B 6.04B 5.42B 4.99B 4.53B 8.58B 8.82B 59.77B 23.81B 303B 22.67B 22.18B 959B P/E 2027 *
31.8x
P/E 2028 * 29.6x
Enterprise Value 541B 5.77B 5.17B 4.77B 4.33B 8.19B 8.42B 57.08B 22.74B 290B 21.65B 21.19B 916B EV / Sales 2027 *
7.16x
EV / Sales 2028 * 6.48x
Free-Float
24.47%
Yield 2027 *
2.53%
Yield 2028 * 2.66%
1 day-1.95%
1 week-3.75%
Current month+2.09%
1 month+1.27%
3 months-6.71%
6 months-5.94%
Current year-10.12%
1 week 26,128.2
Extreme 26128.2
27,243.5
1 month 24,670.1
Extreme 24670.1
27,420
Current year 24,670.1
Extreme 24670.1
29,250
1 year 24,670.1
Extreme 24670.1
30,598
3 years 21,983.4
Extreme 21983.4
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 13/06/2025
Director of Finance/CFO 53 05/05/2025
Director of Finance/CFO - 31/03/2025
Director TitleAgeSince
Director/Board Member 70 28/02/2011
Chairman 71 12/08/2026
Director/Board Member 61 28/10/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.95%-3.75%-11.56%+9.73% 6.04B
+1.44%+1.63%+48.17%+139.63% 1,276B
-0.47%+5.49%+49.03%+90.68% 676B
+0.20%+2.76%+34.37%+112.06% 519B
-0.68%+0.81%+38.24%+67.16% 388B
-0.48%+2.34%+70.66%+46.02% 365B
-0.52%-0.45%+28.42%+57.95% 307B
-0.33%-1.14%+2.96%+35.28% 287B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 212B
Average -0.33%+2.44%+34.87%+75.76% 429B
Weighted average by Cap. -0.19%+2.51%+42.69%+96.46%

Financials

2027 *2028 *
Net sales 75.57B 806M 723M 666M 605M 1.15B 1.18B 7.98B 3.18B 40.49B 3.03B 2.96B 128B 83.24B 888M 796M 734M 666M 1.26B 1.3B 8.79B 3.5B 44.6B 3.33B 3.26B 141B
Net income 17.81B 190M 170M 157M 143M 270M 277M 1.88B 749M 9.54B 713M 698M 30.16B 19.28B 206M 184M 170M 154M 292M 300M 2.04B 811M 10.33B 772M 755M 32.66B
Net Debt -25.49B -272M -244M -225M -204M -386M -397M -2.69B -1.07B -13.66B -1.02B -999M -43.17B -26.98B -288M -258M -238M -216M -409M -420M -2.85B -1.13B -14.46B -1.08B -1.06B -45.7B
Projected Income Statement - Annual - Abbott India Limited
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,679
Date Price Change Volume
11/11/26 ₹26,100.20 -2.06% 8,245
09/11/26 ₹26,648.25 -0.14% 2,278
08/11/26 ₹26,684.90 +1.31% 57
06/11/26 ₹26,340.05 -0.95% 9,447
05/11/26 ₹26,592.70 -2.04% 954
Trader
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Abbott India Limited
  1. Stock Market
  2. Stocks
  3. ABBOTINDIA Stock